Download now: life sciences - whitepaper: building an investable ip portfolio
​

We’re attending CIPA’s 2021 Life Sciences Conference

No items found.
​
30 October 2021
Tags
No items found.
Table of contents
  • Toc Heading
  • Toc Heading

Our Life and HealthTech Practice Groups will attend CIPA’s Life Sciences Conference on the 29 November.

The conference is the UK’s preeminent life sciences event which will provide the opportunity for patent and IP professionals active in the pharma, medical technology and biotechnology sectors to connect and discuss trending topics.

As in previous years, Partner and Head of EIP HealthTech, Gareth Probert will be giving the conference’s annual update on EP case law. He will be highlighting the significant cases and practice changes which will impact how life science companies obtain and challenge patents at the EPO.

EIP Partners, Monika Rai, Andrew Sharples and Darren Smyth will also be in attendance.

If you are interested in meeting us at the event, please email us.

Visit CIPA’s website to find out more about the event.

Related articles

See all articles

EIP named a leading patent firm again in the Legal 500 UK 2027
01 October 2026
EIP has retained its Tier 1 ranking in PATMA: Patents and its Tier 2 ranking in IP: Patents (contentious and non-contentious) in the Legal 500 UK 2027 guide. In addition, Gary Moss was inducted into the Hall of Fame in IP: Patents.
​
Five EIP partners named among the world's leading IP strategists in the 2026 IAM Strategy 300
17 August 2026
Christof Höhne, Darren Smyth, Heather McCann, James Seymour, and Sebastian Fuchs have all been named in this year's list, each recognised for their own approach to building patent value for clients.
​
Stuart Malcolm joins EIP as Partner, Solicitor, strengthening EIP's Commercial practice
17 June 2026
EIP is delighted to announce that Stuart Malcolm has joined EIP as a Partner, Solicitor on 17 June 2026, strengthening our Commercial practice. Stuart brings more than 25 years of experience as a commercial and intellectual property lawyer, with a career spanning private practice, senior in-house leadership, and the United Kingdom's deep tech and innovation sectors.
​